Status:
COMPLETED
Detection of High-Risk HPV in Urine and Cervical Swab Specimen Using HPV Diagnostic Kit (Bio Farma)
Lead Sponsor:
PT Bio Farma
Conditions:
Human Papilloma Virus Infection
Eligibility:
FEMALE
20-50 years
Phase:
NA
Brief Summary
This study is a cross-sectional study to evaluate accuracy of high-risk DNA-HPV testing using HPV Diagnostic Kit (Bio Farma) compared to Standard Kit (COBAS® 6800 HPV from Roche Molecular Systems) RT-...
Eligibility Criteria
Inclusion
- Sexually active female aged 20-50 years
- Willing to participate in study and signed the informed consent form.
Exclusion
- Pregnant women
- History of HIV infection
- On menstruation period
- History of complete HPV vaccination
Key Trial Info
Start Date :
April 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 29 2022
Estimated Enrollment :
900 Patients enrolled
Trial Details
Trial ID
NCT06111911
Start Date
April 1 2022
End Date
October 29 2022
Last Update
November 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cipto Mangunkusumo Hospital
Jakarta, DKI Jakarta, Indonesia, 10430